FDA Drug recall D-1412-2014
Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only
- FDA Drug
- Class II
- terminated
- Published 2014-07-09
On 2014-07-09 the FDA classified a Class II recall of Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only by Forest Pharmaceuticals, citing failed Dissolution Specifications: Drug failed stage III dissolution testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1412-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-06-19 |
| Published | 2014-07-09 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Forest Pharmaceuticals |
| Distribution | US |
Product
Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.
Reason
Failed Dissolution Specifications: Drug failed stage III dissolution testing.
Identifiers
| code_info | Lot # A308879, Expiry: 09/2015 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1412-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.